CurrentUnitedHealthcarePolicy CS127NE.P

Umbilical Cord Blood Harvesting and Storage for Future Use (for Nebraska Only)

State-specific UnitedHealthcare medical policy for Nebraska governing coverage of prophylactic collection and storage of umbilical cord blood for future unspecified autologous or allogeneic use; applies to Nebraska members and providers.

Policy Summary

PayerUnitedHealthcare

PolicyUmbilical Cord Blood Harvesting and Storage for Future Use (for Nebraska Only)

Policy CodePolicy CS127NE.P

Change TypeRefined languageNebraska-specific version

Effective DateOct 1, 2025

Next Review Date

Key ActionDo not authorize prophylactic collection and storage of umbilical cord blood for currently healthy individuals seeking unspecified future autologous or allogeneic transplantation; consider directed/family banking only when a related recipient has a known transplant-treatable disease and document clinical indication.

SourceLink

POLICY UPDATE CHANGES

Replaced prior language about collection and storage being unproven for a person currently healthy desiring hypothetical future transplantation with language stating prophylactic collection and storage is unproven and not medically necessary for an individual currently healthy desiring opportunity for a future unspecified autologous or allogeneic stem cell transplantation.

Created state-specific policy version for the state of Nebraska.

Updated Clinical Evidence and References sections to reflect most current information.

Nebraska-onlypolicy applies to

Not medically necessarystance for prophylactic collection/storage

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria

inv-01: Not medically necessary — prophylactic collection/storage

Not covered when the following condition applies

Prophylactic storage not medically necessary: Prophylactic collection and storage of umbilical cord blood for an individual who is currently healthy but desiring to provide the opportunity for a future unspecified autologous or allogeneic stem cell transplantation is unproven and not medically necessary due to insufficient evidence of efficacy.

Refer to Hematopoietic Stem Cell Transplantation guideline for transplantation coverage; directed banking may be appropriate if a family member has a known condition treatable with transplant.

inv-02: Directed/Family banking — recommended in select circumstances

Coverage consideration for directed/family banking

Directed banking for known at-risk family member: Collection and storage of cord blood may be recommended/considered when there is knowledge of a sibling or family member with a disease that could be successfully treated with allogeneic cord blood transplantation or when a family predisposition indicates likely therapeutic use.

Society guidance (ASTCT/ASBMT, ACOG, AMA) supports directed/family banking in such circumstances; routine private banking for low-risk families is not recommended.

Routine private banking of umbilical cord blood purely for prophylactic storage in a currently healthy individual for unspecified future use is not medically necessary. The policy considers prophylactic collection and storage unproven due to insufficient evidence of efficacy for a hypothetical future autologous or allogeneic stem cell transplantation and such requests may be denied.

Specifically, collection and cryopreservation of cord blood solely to provide the opportunity for a future unspecified transplant—whether autologous or allogeneic—is considered unproven and not medically necessary when the donor (newborn) is currently healthy and there is no identified family member with a condition likely to require allogeneic transplantation. Refer to the Hematopoietic Stem Cell Transplantation guideline for coverage of transplant procedures and to society guidance when directed/family banking is being considered for a known at‑risk relative.

Coding

Procedure codes (reference)mixed

38205	Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; allogeneic
38206	Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous
38207	Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage
88240	Cryopreservation, freezing and storage of cells, each cell line
S2140	Cord blood harvesting for transplantation, allogeneic

Coding ancillary notes

ThresholdsN/A

NoteProcedure codes are provided for reference only and do not imply coverage or reimbursement.

Prior authorizationFollow applicable plan rules and contract terms for any prior authorization requirements.

Provider Actions and Billing Notes

Prior Authorization

Applicable Codes and Prior Authorization Note

The following procedure and diagnosis codes are provided for reference only. Inclusion of a code does not guarantee coverage or payment; verify member benefits and applicable federal, state, or contractual requirements before billing.

CPT and HCPCS listings are for reference and may not be all-inclusive.
CPT is a registered trademark of the American Medical Association.

Step Therapy

No step therapy requirements are specified in this policy for cord blood collection or storage.

Documentation Required

Documentation Guidance

Background

Umbilical cord and placental blood contain hematopoietic stem cells that can be used in treatment of hematologic malignancies, marrow failure, and certain metabolic or immunologic disorders. Cord blood banking involves collection at birth and cryogenic storage of these cells for potential future autologous or family use. However, because prophylactic storage for a currently healthy individual seeking unspecified future use lacks sufficient evidence of benefit, it is not covered under this policy.

Definitions

Cord blood banking definition

DefinitionCord blood banking is the process of collecting umbilical cord and placental blood at birth and cryogenically storing it for potential future transplant use.

Primary useSource of hematopoietic (blood-forming) stem cells for treating diseases such as leukemia, lymphoma, myeloma, aplastic anemia, and certain immunologic and metabolic disorders.

ProcessSalvaging cord and placental blood and cryogenically freezing it immediately after the birthing process for future transplantation.

Private vs public banking

Private (directed) bankingStores cord blood for future use by the child (autologous) or a family member (allogeneic) should the need arise.

Public bankingAccepts cord blood donations and makes them available to any matched recipient in need of a transplant due to illness.